INSYS Therapeutics Inc (NASDAQ:INSY)

7.01
Delayed Data
As of Apr 25
 +0.11 / +1.59%
Today’s Change
4.10
Today|||52-Week Range
15.02
-27.13%
Year-to-Date
No recent news for INSYS Therapeutics Inc.

Today’s Trading

Previous close6.90
Today’s open6.91
Day’s range6.76 - 7.07
Volume331,820
Average volume (3 months)1,288,067
Market cap$548.4M
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)-3,260.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)-41.93%
P/E ratioNM
Price/Sales4.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...+0.15+1.15%
SGYPSynergy Pharmaceutic...-0.07-4.22%
LCILannett Company Inc-0.15-0.94%
VSARVersartis Inc+0.02+1.67%
Data as of 4:01pm ET, 04/25/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$140.7M
Annual profit (last year)-$228.0M
Net profit margin-162.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Saeed Motahari
CFO &
Principal Accounting Officer
Andrew G. Long
Corporate headquarters
Chandler, Arizona

Forecasts